nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—CYP19A1—Tamoxifen—pancreatic cancer	0.503	1	CbGbCtD
Nandrolone decanoate—Precocious puberty—Tamoxifen—pancreatic cancer	0.0632	0.162	CcSEcCtD
Nandrolone decanoate—Peliosis hepatis—Tamoxifen—pancreatic cancer	0.042	0.107	CcSEcCtD
Nandrolone decanoate—Oligomenorrhoea—Tamoxifen—pancreatic cancer	0.034	0.0871	CcSEcCtD
Nandrolone decanoate—Oligospermia—Gemcitabine—pancreatic cancer	0.0173	0.0442	CcSEcCtD
Nandrolone decanoate—Azoospermia—Gemcitabine—pancreatic cancer	0.0134	0.0344	CcSEcCtD
Nandrolone decanoate—Priapism—Tamoxifen—pancreatic cancer	0.0109	0.0279	CcSEcCtD
Nandrolone decanoate—Hirsutism—Erlotinib—pancreatic cancer	0.00896	0.0229	CcSEcCtD
Nandrolone decanoate—Oligospermia—Epirubicin—pancreatic cancer	0.00826	0.0211	CcSEcCtD
Nandrolone decanoate—Oligospermia—Doxorubicin—pancreatic cancer	0.00765	0.0196	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Tamoxifen—pancreatic cancer	0.0073	0.0187	CcSEcCtD
Nandrolone decanoate—Azoospermia—Epirubicin—pancreatic cancer	0.00643	0.0165	CcSEcCtD
Nandrolone decanoate—Local reaction—Fluorouracil—pancreatic cancer	0.00643	0.0164	CcSEcCtD
Nandrolone decanoate—Acne—Erlotinib—pancreatic cancer	0.00619	0.0158	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Tamoxifen—pancreatic cancer	0.00599	0.0153	CcSEcCtD
Nandrolone decanoate—Azoospermia—Doxorubicin—pancreatic cancer	0.00595	0.0152	CcSEcCtD
Nandrolone decanoate—Acne—Sunitinib—pancreatic cancer	0.00536	0.0137	CcSEcCtD
Nandrolone decanoate—Fluid retention—Tamoxifen—pancreatic cancer	0.005	0.0128	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.00439	0.0413	CbGpPWpGaD
Nandrolone decanoate—Hepatic function abnormal—Tamoxifen—pancreatic cancer	0.00437	0.0112	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—NR5A2—pancreatic cancer	0.00414	0.0389	CbGpPWpGaD
Nandrolone decanoate—Furunculosis—Epirubicin—pancreatic cancer	0.00407	0.0104	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—pancreatic cancer	0.00377	0.00964	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Sunitinib—pancreatic cancer	0.00375	0.00958	CcSEcCtD
Nandrolone decanoate—Furuncle—Epirubicin—pancreatic cancer	0.00353	0.00903	CcSEcCtD
Nandrolone decanoate—Fluid retention—Gemcitabine—pancreatic cancer	0.00343	0.00879	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—RBBP8—pancreatic cancer	0.00331	0.0311	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00327	0.0307	CbGpPWpGaD
Nandrolone decanoate—Furuncle—Doxorubicin—pancreatic cancer	0.00327	0.00836	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—pancreatic cancer	0.00313	0.008	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00304	0.00778	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.00301	0.00769	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00299	0.0281	CbGpPWpGaD
Nandrolone decanoate—Amenorrhoea—Docetaxel—pancreatic cancer	0.00292	0.00748	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—pancreatic cancer	0.00289	0.0074	CcSEcCtD
Nandrolone decanoate—MAOA—Oxidative Stress—NFE2L2—pancreatic cancer	0.0027	0.0253	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00257	0.0242	CbGpPWpGaD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—pancreatic cancer	0.00254	0.0065	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.00248	0.0233	CbGpPWpGaD
Nandrolone decanoate—Irritability—Fluorouracil—pancreatic cancer	0.00246	0.00631	CcSEcCtD
Nandrolone decanoate—Fluid retention—Docetaxel—pancreatic cancer	0.00244	0.00624	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—pancreatic cancer	0.0024	0.00615	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00236	0.00603	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—pancreatic cancer	0.00235	0.00601	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.0023	0.0216	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00227	0.0213	CbGpPWpGaD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—pancreatic cancer	0.00222	0.00569	CcSEcCtD
Nandrolone decanoate—Dysphonia—Epirubicin—pancreatic cancer	0.0021	0.00539	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00204	0.00522	CcSEcCtD
Nandrolone decanoate—Jaundice—Irinotecan—pancreatic cancer	0.00203	0.00518	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.00202	0.0189	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Tamoxifen—pancreatic cancer	0.00199	0.00508	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Epirubicin—pancreatic cancer	0.00197	0.00504	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00195	0.0183	CbGpPWpGaD
Nandrolone decanoate—Dysphonia—Doxorubicin—pancreatic cancer	0.00195	0.00498	CcSEcCtD
Nandrolone decanoate—Oedema—Tamoxifen—pancreatic cancer	0.00188	0.00481	CcSEcCtD
Nandrolone decanoate—Oedema—Erlotinib—pancreatic cancer	0.00186	0.00475	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—pancreatic cancer	0.00182	0.00467	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.00182	0.0171	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Sunitinib—pancreatic cancer	0.0017	0.00435	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00168	0.0043	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—pancreatic cancer	0.00164	0.00421	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00164	0.00419	CcSEcCtD
Nandrolone decanoate—Oedema—Sunitinib—pancreatic cancer	0.00161	0.00412	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.00156	0.0146	CbGpPWpGaD
Nandrolone decanoate—Fluid retention—Doxorubicin—pancreatic cancer	0.00152	0.00389	CcSEcCtD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD2—pancreatic cancer	0.0015	0.0141	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Tamoxifen—pancreatic cancer	0.00149	0.00382	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00144	0.00368	CcSEcCtD
Nandrolone decanoate—Hypertension—Irinotecan—pancreatic cancer	0.0014	0.00359	CcSEcCtD
Nandrolone decanoate—Jaundice—Docetaxel—pancreatic cancer	0.0014	0.00358	CcSEcCtD
Nandrolone decanoate—Hypertension—Gemcitabine—pancreatic cancer	0.00137	0.00349	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00136	0.0127	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—TSC2—pancreatic cancer	0.00133	0.0125	CbGpPWpGaD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00133	0.0034	CcSEcCtD
Nandrolone decanoate—Pruritus—Tamoxifen—pancreatic cancer	0.00133	0.0034	CcSEcCtD
Nandrolone decanoate—Oedema—Irinotecan—pancreatic cancer	0.00133	0.00339	CcSEcCtD
Nandrolone decanoate—Pruritus—Erlotinib—pancreatic cancer	0.00131	0.00336	CcSEcCtD
Nandrolone decanoate—Oedema—Gemcitabine—pancreatic cancer	0.00129	0.0033	CcSEcCtD
Nandrolone decanoate—Oedema—Fluorouracil—pancreatic cancer	0.00127	0.00325	CcSEcCtD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—APOE—pancreatic cancer	0.00126	0.0119	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.00119	0.0112	CbGpPWpGaD
Nandrolone decanoate—Rash—Tamoxifen—pancreatic cancer	0.00118	0.00303	CcSEcCtD
Nandrolone decanoate—Dermatitis—Tamoxifen—pancreatic cancer	0.00118	0.00303	CcSEcCtD
Nandrolone decanoate—Rash—Erlotinib—pancreatic cancer	0.00117	0.003	CcSEcCtD
Nandrolone decanoate—Dermatitis—Erlotinib—pancreatic cancer	0.00117	0.00299	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00116	0.00297	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00116	0.0109	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Sunitinib—pancreatic cancer	0.00114	0.00291	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00112	0.0105	CbGpPWpGaD
Nandrolone decanoate—Nausea—Tamoxifen—pancreatic cancer	0.00112	0.00285	CcSEcCtD
Nandrolone decanoate—Nausea—Erlotinib—pancreatic cancer	0.0011	0.00282	CcSEcCtD
Nandrolone decanoate—MAOB—Alpha-synuclein signaling—SRC—pancreatic cancer	0.00106	0.00993	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00102	0.00961	CbGpPWpGaD
Nandrolone decanoate—Rash—Sunitinib—pancreatic cancer	0.00101	0.00259	CcSEcCtD
Nandrolone decanoate—Dermatitis—Sunitinib—pancreatic cancer	0.00101	0.00259	CcSEcCtD
Nandrolone decanoate—Urticaria—Fluorouracil—pancreatic cancer	0.00101	0.00258	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.001	0.00943	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.000997	0.00936	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000986	0.00926	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000985	0.00925	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Docetaxel—pancreatic cancer	0.000969	0.00248	CcSEcCtD
Nandrolone decanoate—Nausea—Sunitinib—pancreatic cancer	0.000956	0.00244	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.000953	0.00895	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Epirubicin—pancreatic cancer	0.000944	0.00242	CcSEcCtD
Nandrolone decanoate—Oedema—Docetaxel—pancreatic cancer	0.000916	0.00234	CcSEcCtD
Nandrolone decanoate—Pruritus—Gemcitabine—pancreatic cancer	0.000913	0.00234	CcSEcCtD
Nandrolone decanoate—Pruritus—Fluorouracil—pancreatic cancer	0.000898	0.0023	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.000898	0.00843	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000879	0.00825	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Doxorubicin—pancreatic cancer	0.000874	0.00224	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.000861	0.00808	CbGpPWpGaD
Nandrolone decanoate—Rash—Irinotecan—pancreatic cancer	0.000836	0.00214	CcSEcCtD
Nandrolone decanoate—Dermatitis—Irinotecan—pancreatic cancer	0.000835	0.00214	CcSEcCtD
Nandrolone decanoate—Rash—Gemcitabine—pancreatic cancer	0.000814	0.00208	CcSEcCtD
Nandrolone decanoate—Dermatitis—Gemcitabine—pancreatic cancer	0.000813	0.00208	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	0.000811	0.00762	CbGpPWpGaD
Nandrolone decanoate—Rash—Fluorouracil—pancreatic cancer	0.0008	0.00205	CcSEcCtD
Nandrolone decanoate—Dermatitis—Fluorouracil—pancreatic cancer	0.000799	0.00205	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000794	0.00745	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.000788	0.0074	CbGpPWpGaD
Nandrolone decanoate—Nausea—Irinotecan—pancreatic cancer	0.000787	0.00201	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000784	0.00201	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000775	0.00728	CbGpPWpGaD
Nandrolone decanoate—Nausea—Gemcitabine—pancreatic cancer	0.000767	0.00196	CcSEcCtD
Nandrolone decanoate—Nausea—Fluorouracil—pancreatic cancer	0.000754	0.00193	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	0.000752	0.00706	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.000741	0.00695	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	0.000731	0.00686	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000725	0.00186	CcSEcCtD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—SRC—pancreatic cancer	0.000723	0.00679	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000695	0.00653	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	0.000681	0.00639	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Epirubicin—pancreatic cancer	0.000654	0.00167	CcSEcCtD
Nandrolone decanoate—Pruritus—Docetaxel—pancreatic cancer	0.000648	0.00166	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.000638	0.00599	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000636	0.00597	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000623	0.00585	CbGpPWpGaD
Nandrolone decanoate—Oedema—Epirubicin—pancreatic cancer	0.000618	0.00158	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000616	0.00578	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Doxorubicin—pancreatic cancer	0.000605	0.00155	CcSEcCtD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	0.000579	0.00543	CbGpPWpGaD
Nandrolone decanoate—Rash—Docetaxel—pancreatic cancer	0.000578	0.00148	CcSEcCtD
Nandrolone decanoate—Dermatitis—Docetaxel—pancreatic cancer	0.000577	0.00148	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	0.000572	0.00537	CbGpPWpGaD
Nandrolone decanoate—Oedema—Doxorubicin—pancreatic cancer	0.000572	0.00146	CcSEcCtD
Nandrolone decanoate—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000565	0.00531	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000561	0.00526	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.000549	0.00516	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.000547	0.00513	CbGpPWpGaD
Nandrolone decanoate—Nausea—Docetaxel—pancreatic cancer	0.000544	0.00139	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000538	0.00505	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	0.000529	0.00497	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000529	0.00497	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	0.000528	0.00496	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	0.00052	0.00488	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	0.000508	0.00477	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.000494	0.00464	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Epirubicin—pancreatic cancer	0.000491	0.00126	CcSEcCtD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.00049	0.0046	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	0.000489	0.00459	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	0.000487	0.00457	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	0.000484	0.00455	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000479	0.0045	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.00047	0.00442	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	0.000467	0.00439	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	0.000466	0.00437	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000455	0.00428	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Doxorubicin—pancreatic cancer	0.000454	0.00116	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000453	0.00425	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—AKT1—pancreatic cancer	0.000449	0.00422	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Epirubicin—pancreatic cancer	0.000437	0.00112	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.000425	0.00399	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	0.000422	0.00397	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000412	0.00387	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.00041	0.00385	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—pancreatic cancer	0.000404	0.00103	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000402	0.00377	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000397	0.00373	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	0.000394	0.0037	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000391	0.00367	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	0.00039	0.00366	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.00039	0.00366	CbGpPWpGaD
Nandrolone decanoate—Rash—Epirubicin—pancreatic cancer	0.00039	0.000997	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—pancreatic cancer	0.000389	0.000996	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	0.000382	0.00359	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000382	0.00358	CbGpPWpGaD
Nandrolone decanoate—Nausea—Epirubicin—pancreatic cancer	0.000367	0.000939	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.000361	0.00339	CbGpPWpGaD
Nandrolone decanoate—Rash—Doxorubicin—pancreatic cancer	0.00036	0.000922	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—pancreatic cancer	0.00036	0.000921	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.000358	0.00336	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.000349	0.00328	CbGpPWpGaD
Nandrolone decanoate—Nausea—Doxorubicin—pancreatic cancer	0.00034	0.000869	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000337	0.00316	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000336	0.00316	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CHD3—pancreatic cancer	0.000325	0.00305	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000325	0.00305	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.000323	0.00304	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000319	0.00299	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000318	0.00298	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	0.000316	0.00296	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000313	0.00293	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.000312	0.00293	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000308	0.00289	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PRSS1—pancreatic cancer	0.000297	0.00279	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000295	0.00277	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.000284	0.00266	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000283	0.00265	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000274	0.00258	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000273	0.00257	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NR5A2—pancreatic cancer	0.000272	0.00256	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	0.000272	0.00255	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000262	0.00246	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ARG2—pancreatic cancer	0.000258	0.00242	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000248	0.00232	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000243	0.00228	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000237	0.00223	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000237	0.00222	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000234	0.0022	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000229	0.00215	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000228	0.00214	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TYMP—pancreatic cancer	0.000225	0.00212	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000218	0.00205	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000217	0.00204	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000217	0.00204	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000209	0.00197	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000209	0.00196	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000206	0.00194	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000204	0.00191	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000202	0.00189	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000202	0.00189	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000202	0.00189	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000201	0.00189	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000201	0.00189	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000197	0.00185	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000197	0.00185	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000196	0.00184	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000194	0.00182	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.00019	0.00178	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000189	0.00178	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PRSS1—pancreatic cancer	0.000187	0.00175	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000186	0.00174	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PRSS1—pancreatic cancer	0.000182	0.00171	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GLP1R—pancreatic cancer	0.000182	0.00171	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—DPYD—pancreatic cancer	0.000179	0.00168	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000178	0.00167	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000177	0.00167	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000176	0.00165	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000175	0.00165	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000172	0.00162	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000171	0.00161	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC2A2—pancreatic cancer	0.00017	0.00159	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000163	0.00153	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ARG2—pancreatic cancer	0.000162	0.00152	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.00016	0.0015	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ARG2—pancreatic cancer	0.000158	0.00148	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000157	0.00148	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000157	0.00147	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MEN1—pancreatic cancer	0.000156	0.00147	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000156	0.00146	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000154	0.00145	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000152	0.00143	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000151	0.00142	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH4—pancreatic cancer	0.000148	0.00139	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000147	0.00138	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000145	0.00137	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000145	0.00136	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TYMP—pancreatic cancer	0.000141	0.00133	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HSPA1B—pancreatic cancer	0.000141	0.00133	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TYMP—pancreatic cancer	0.000138	0.0013	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000137	0.00129	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000134	0.00126	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000134	0.00125	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000132	0.00124	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CD44—pancreatic cancer	0.000131	0.00123	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000129	0.00121	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EZH2—pancreatic cancer	0.000129	0.00121	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH3—pancreatic cancer	0.000126	0.00118	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GCG—pancreatic cancer	0.000126	0.00118	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HSPA1A—pancreatic cancer	0.000119	0.00112	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—STK11—pancreatic cancer	0.000118	0.00111	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GLP1R—pancreatic cancer	0.000114	0.00107	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000114	0.00107	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000113	0.00106	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—DPYD—pancreatic cancer	0.000112	0.00105	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GLP1R—pancreatic cancer	0.000111	0.00104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—DPYD—pancreatic cancer	0.000109	0.00103	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000109	0.00102	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC2A2—pancreatic cancer	0.000106	0.001	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000105	0.000987	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	0.000104	0.000975	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000103	0.000965	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TYMS—pancreatic cancer	0.000102	0.000957	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.92e-05	0.000931	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SMAD4—pancreatic cancer	9.49e-05	0.000891	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.03e-05	0.000848	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—APOE—pancreatic cancer	8.28e-05	0.000778	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CD44—pancreatic cancer	8.24e-05	0.000774	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—HRAS—pancreatic cancer	8.05e-05	0.000756	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CD44—pancreatic cancer	8.04e-05	0.000755	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GCG—pancreatic cancer	7.9e-05	0.000742	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.87e-05	0.000739	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—pancreatic cancer	7.82e-05	0.000734	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.8e-05	0.000733	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GCG—pancreatic cancer	7.71e-05	0.000724	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CG—pancreatic cancer	7.48e-05	0.000702	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—STK11—pancreatic cancer	7.43e-05	0.000698	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—STK11—pancreatic cancer	7.25e-05	0.000681	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPARG—pancreatic cancer	7.22e-05	0.000678	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH1—pancreatic cancer	6.99e-05	0.000657	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.8e-05	0.000639	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PPARG—pancreatic cancer	6.6e-05	0.00062	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CD—pancreatic cancer	6.57e-05	0.000617	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TYMS—pancreatic cancer	6.39e-05	0.0006	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TYMS—pancreatic cancer	6.23e-05	0.000585	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CB—pancreatic cancer	5.73e-05	0.000538	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—pancreatic cancer	5.68e-05	0.000533	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—APOE—pancreatic cancer	5.2e-05	0.000488	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—APOE—pancreatic cancer	5.07e-05	0.000476	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—pancreatic cancer	4.95e-05	0.000465	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.8e-05	0.000451	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CG—pancreatic cancer	4.69e-05	0.000441	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	4.58e-05	0.00043	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARG—pancreatic cancer	4.53e-05	0.000425	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARG—pancreatic cancer	4.42e-05	0.000415	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CD—pancreatic cancer	4.12e-05	0.000387	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	4.02e-05	0.000378	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—pancreatic cancer	3.76e-05	0.000353	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CB—pancreatic cancer	3.59e-05	0.000338	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—pancreatic cancer	3.56e-05	0.000334	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	3.51e-05	0.000329	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CA—pancreatic cancer	3.49e-05	0.000328	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—pancreatic cancer	3.47e-05	0.000326	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—pancreatic cancer	3.11e-05	0.000292	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—pancreatic cancer	3.03e-05	0.000285	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—pancreatic cancer	2.85e-05	0.000268	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—pancreatic cancer	2.61e-05	0.000245	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CA—pancreatic cancer	2.19e-05	0.000206	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	2.14e-05	0.000201	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—pancreatic cancer	1.79e-05	0.000168	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—pancreatic cancer	1.75e-05	0.000164	CbGpPWpGaD
